Atomistry » Chlorine » PDB 6frq-6g1n » 6fyl
Atomistry »
  Chlorine »
    PDB 6frq-6g1n »
      6fyl »

Chlorine in PDB 6fyl: X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A

Enzymatic activity of X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A

All present enzymatic activity of X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A:
2.7.12.1;

Protein crystallography data

The structure of X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A, PDB code: 6fyl was solved by J.Kallen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 19.57 / 1.95
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 39.631, 75.997, 111.701, 90.00, 90.00, 90.00
R / Rfree (%) 18.8 / 21.3

Chlorine Binding Sites:

The binding sites of Chlorine atom in the X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A (pdb code 6fyl). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A, PDB code: 6fyl:

Chlorine binding site 1 out of 1 in 6fyl

Go back to Chlorine Binding Sites List in 6fyl
Chlorine binding site 1 out of 1 in the X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of X-Ray Structure of CLK2-Kd(136-496)/Cx-4945 at 1.95A within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl501

b:28.9
occ:1.00
CL22 A:3NG501 0.0 28.9 1.0
C18 A:3NG501 1.7 24.8 1.0
C17 A:3NG501 2.7 22.7 1.0
C19 A:3NG501 2.7 24.8 1.0
CZ A:PHE174 3.2 26.3 0.5
N A:GLU171 3.5 25.3 1.0
CE1 A:PHE174 3.6 26.4 0.5
C A:GLU171 3.6 26.7 1.0
C A:GLY170 3.7 24.4 1.0
O A:GLU171 3.8 26.7 1.0
CA A:GLU171 3.8 26.7 1.0
N A:GLY172 3.9 26.9 1.0
CG2 A:VAL177 3.9 20.5 1.0
O A:GLY170 3.9 23.5 1.0
C16 A:3NG501 4.0 20.8 1.0
C20 A:3NG501 4.0 24.1 1.0
CA A:GLY170 4.3 24.2 1.0
CE2 A:PHE174 4.3 26.5 0.5
N A:VAL177 4.3 21.5 1.0
O A:GLY175 4.5 24.2 1.0
CA A:GLY172 4.5 27.5 1.0
C21 A:3NG501 4.5 22.4 1.0
CB A:VAL177 4.5 20.9 1.0
O A:HOH850 4.8 43.4 1.0
CA A:ARG176 4.9 22.9 1.0
C A:ARG176 4.9 22.0 1.0
CD1 A:PHE174 4.9 25.7 0.5

Reference:

J.Kallen, C.Bergsdorf, B.Arnaud, M.Bernhard, M.Brichet, A.Cobos-Correa, A.Elhajouji, F.Freuler, I.Galimberti, C.Guibourdenche, S.Haenni, S.Holzinger, J.Hunziker, A.Izaac, M.Kaufmann, L.Leder, H.J.Martus, P.Von Matt, V.Polyakov, P.Roethlisberger, G.Roma, N.Stiefl, M.Uteng, A.Lerchner. X-Ray Structures and Feasibility Assessment of CLK2 Inhibitors For Phelan-Mcdermid Syndrome. Chemmedchem V. 13 1997 2018.
ISSN: ESSN 1860-7187
PubMed: 29985556
DOI: 10.1002/CMDC.201800344
Page generated: Sat Jul 27 23:35:42 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy